We’ve recently updated our valuation analysis.

INSPECS Group Valuation

Is SPEC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SPEC?

Other financial metrics that can be useful for relative valuation.

SPEC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.7x
Enterprise Value/EBITDA7.8x
PEG Ration/a

Price to Sales Ratio vs Peers

How does SPEC's PS Ratio compare to its peers?

The above table shows the PS ratio for SPEC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average4.6x
RUA RUA Life Sciences
7xn/aUK£13.2m
TSTL Tristel
5.2x10.2%UK£163.0m
ABDX Abingdon Health
5.4xn/aUK£15.2m
MHC MyHealthChecked
0.5xn/aUK£12.1m
SPEC INSPECS Group
0.5x1.3%UK£95.6m

Price-To-Sales vs Peers: SPEC is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (4.6x).


Price to Earnings Ratio vs Industry

How does SPEC's PE Ratio compare vs other companies in the GB Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.1%
n/an/an/a

Price-To-Sales vs Industry: SPEC is good value based on its Price-To-Sales Ratio (0.5x) compared to the UK Medical Equipment industry average (2.8x)


Price to Sales Ratio vs Fair Ratio

What is SPEC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SPEC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ratio1.4x

Price-To-Sales vs Fair Ratio: SPEC is good value based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (1.4x).


Share Price vs Fair Value

What is the Fair Price of SPEC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SPEC (£1.02) is trading above our estimate of fair value (£1.02)

Significantly Below Fair Value: SPEC is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies